Development of Russian market for postgenome technologies

We performed the analysis of the markets and sectors of the economy, the development of which is ensured by the implementation of the priority 20v «The transition to personalized medicine, high-tech health care and health protection technologies» in the field of post-genomic technologies, including genome editing and molecular profiling, based on the analysis of big data, considering the key Russian and foreign strategic and forecast documents, forecasts of large corporations and consulting agencies, news and scientific open Russian and foreign resources. The analysis showed the active development of the market for post-genomic technologies in Russia. Market segments demonstrated high growth rates, following in line with global trends. State institutions had adopted a number of programs aimed at supporting and developing the sector of practical implementation of post-genomic technologies. The policy of the Government of the Russian Federation, aimed at importing foreign drugs and medical products, created a full cycle of domestic production of targeted drugs for personalized therapy of malignant tumors.